Eupraxia Pharmaceuticals (EPRX) Institutional Ownership $3.12 -0.01 (-0.32%) (As of 11/18/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$33.54KNumber ofInstitutional Sellers(last 12 months)0 Get EPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eupraxia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceAmerica’s future explained in one mapA silent invasion is about to change everything. Will you be prepared?Click the map to find out what happens next Eupraxia Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/17/2024 180 Wealth Advisors LLC13,000$34K0.0%N/A0.048% (Data available from 1/1/2016 forward) EPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EPRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals shares: 180 Wealth Advisors LLC ($34K).Learn more on EPRX's institutional investors. Which institutional investors have been buying Eupraxia Pharmaceuticals stock? The following institutional investors have purchased Eupraxia Pharmaceuticals stock in the last 24 months: 180 Wealth Advisors LLC ($13K). How much institutional buying is happening at Eupraxia Pharmaceuticals? Institutional investors have bought a total of 13,000 shares in the last 24 months. This purchase volume represents approximately $33.54K in transactions. Related Companies Kamada Institutional Ownership Jasper Therapeutics Institutional Ownership Design Therapeutics Institutional Ownership SNDL Institutional Ownership AC Immune Institutional Ownership Alpha Teknova Institutional Ownership ProQR Therapeutics Institutional Ownership Sage Therapeutics Institutional Ownership Voyager Therapeutics Institutional Ownership Lyell Immunopharma Institutional Ownership This page (NASDAQ:EPRX) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
